However, further studies on signaling pathways involved in chronic inflammation-induced CRC, such as MAPK, IL-6/STAT3, COX-2/PGE2, and IL-23/Th17, are necessary to investigate the protective effect of DRB in the pathogenesis of colitis-associated CRC. This evidence concerns the gene IL6 and colorectal carcinoma.